Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ralph Tyler's Departure As FDA Chief Counsel Leaves Another Chair To Fill

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA has not yet named an interim replacement; the agency has more than a dozen leadership positions being filled on an acting basis and five vacancies.

You may also be interested in...



Spielberg’s Replacement At FDA Also Will Have Strong Industry Ties

Former J&J and Sandoz executive Leona Brenner-Gati to become acting deputy commissioner for medical products and tobacco following the departure of Stephen Spielberg.

FDA's Elizabeth Dickinson Is Named Acting Chief Counsel

Dickinson, who has been a staff attorney since 1994, takes the helm from Ralph Tyler on an interim basis.

FDA's Elizabeth Dickinson Is Named Acting Chief Counsel

Dickinson, who has been a staff attorney since 1994, takes the helm from Ralph Tyler on an interim basis.

Related Content

Topics

UsernamePublicRestriction

Register

MT142539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel